
IsoPlexis Corporation
ISONASDAQHealthcare
$0.76
+$0.00(+0.00%)
Market Cap$30283577
P/E Ratio—
52W High$3.84
52W Low$0.6001
IsoPlexis Corporation(ISO)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · ISO · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $16.76M | $17.26M | $10.39M | $7.50M |
| Cost of Revenue | $17.69M | $8.49M | $4.97M | $3.26M |
| Gross Profit | ($0.93M) | $8.77M | $5.41M | $4.25M |
| Gross Margin %(computed) | -5.52% | 50.79% | 52.11% | 56.59% |
| Operating Expenses | ||||
| R&D Expenses | $23.50M | $20.97M | $11.16M | $10.13M |
| G&A Expenses | $42.68M | $26.35M | $8.02M | $4.81M |
| Total Operating Expenses | $95.57M | $85.09M | $28.57M | $17.86M |
| Operating Income | ($101.23M) | ($76.32M) | ($23.16M) | ($13.62M) |
| Operating Margin %(computed) | -603.96% | -442.25% | -222.98% | -181.41% |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $5.34M | $3.62M | $0.02M | $0.00M |
| Income Before Tax | ($106.00M) | ($81.57M) | ($23.26M) | ($13.63M) |
| Income Tax Expense | $9.51M | $1.99M | $0.02M | $0.00M |
| Net Income | ($115.50M) | ($83.56M) | ($23.29M) | ($13.63M) |
| Net Margin %(computed) | -689.12% | -484.18% | -224.17% | -181.57% |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-2.94 | $-8.16 | $-0.60 | $-0.35 |
| Wtd Avg Shares | 39.32M | 10.24M | 38.84M | 38.84M |
| EBITDA | ($91.54M) | ($77.27M) | ($22.28M) | ($13.12M) |
| EBITDA Margin %(computed) | -546.17% | -447.75% | -214.49% | -174.78% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · M
深入了解IsoPlexis Corporation
关于IsoPlexis Corporation(ISO)损益表
IsoPlexis Corporation(ISO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年,ISO实现营收$0.02B,毛利润($0.00B)(毛利率-5.52%),净利润($0.12B)(净利率-689.12%)。
常见问题
ISO · 4 问IsoPlexis Corporation(ISO)2022财年营收为$0.02B,同比down2.9%。
ISO revenueISO salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09